Results 241 to 250 of about 99,821 (298)

Coagulation protease-activated receptor-2 (PAR2) promotes dyslipidemia, obesity and MASLD through repression of the hepatic pioneer factor HNF4α. [PDF]

JHEP Rep
Chen X, Nguyen N, Turner SE, Tai AK, Abdelmalek MF, Covic L, Kuliopulos A.   +6 more
europepmc   +1 more source

Position-5-driven reorientation of an immunodominant HLA-A*24:02 SARS-CoV-2 epitope drives universal T cell escape. [PDF]

JCI Insight
Nakama T, Wall A, Dolton G, Tan LR, Thomas H, Hamana H, Aritsu Y, Tan TS, Toyoda M, Goto Y, Li H, Kitamatsu M, Udaka K, Miyashita Y, Oshiumi H, Nakamura K, Nagasaki Y, Minami R, Nakata H, Rizkallah PJ, Kishi H, Ueno T, Sewell AK, Motozono C.   +23 more
europepmc   +1 more source

Improved patient models for simulation of clinically realistic ⁶⁸Ga-SSTR PET and ¹⁷⁷Lu-PRRT SPECT studies. [PDF]

EJNMMI Phys
Gustafsson J, Kalaitzidis P, Curkic Kapidzic S, Ljungberg M, Sjögreen Gleisner K.   +4 more
europepmc   +1 more source

Salivary Antioxidant and Peroxidase Activity as a Marker of Steroid Hormone Receptor Expression in Breast Cancer. [PDF]

Int J Mol Sci
Sarf EA, Bel'skaya LV.
europepmc   +1 more source

Characterization of KPC-160, a novel Ω-loop-deleted KPC variant on a dual-copy plasmid that confers cefiderocol resistance. [PDF]

Antimicrob Agents Chemother
Liu Y, Hong H, Huang Q, Fan L, Liu P, Wei D, Liu Y.   +6 more
europepmc   +1 more source

Comparative study of cardio-protective effect of metformin versus dapagliflozin in experimentally induced myocardial infarction in diabetic rats. [PDF]

BMC Pharmacol Toxicol
Elhantery D, Mokbel SA, Hussein AM, Tayee EM, Desouky SE, Taha AM.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

New Heterocyclic Ligands for the Adenosine Receptors P1 and for the ATP Receptors P2

ChemInform, 2005
AbstractFor Abstract see ChemInform Abstract in Full Text.
BARALDI, Pier Giovanni, ROMAGNOLI, Romeo, AGHAZADEH TABRIZI, Mojgan, BOVERO, Andrea, PRETI, Delia, FRUTTAROLO, Francesca, Moorman AR, BOREA, Pier Andrea   +7 more
openaire   +5 more sources

P1- and P2-purine receptors in brain circulation

European Journal of Pharmacology, 1987
As there is increasing evidence that purines are involved in cerebral vasodilatation, purine receptors were characterized pharmacologically in pial arteries from rabbit, cat and man, and compared with purine receptors in various non-cerebral vascular beds.
J E, Hardebo, J, Kåhrström, C, Owman
openaire   +2 more sources

Adenosine (P1) receptor signalling

Drug Development Research, 1996
The coupling of the four defined types of adenosine receptors to G proteins and the consequent activation of effector pathways is briefly summarized. It is pointed out that the G proteins are able to influence many types of cellular effector systems, and, in particular, that the a and the β,γ-subunits may activate different signalling pathways that may
Bertil B. Fredholm, Giulia Arslan, Bj�rn Kull, Ewa Kontny, Per Svenningsson   +4 more
openaire   +1 more source

Molecular architecture of mouse activating NKR-P1 receptors

Journal of Structural Biology, 2011
Receptors belonging to NKR-P1 family and their specific Clr ligands form an alternative missing self recognition system critical in immunity against tumors and viruses, elimination of tumor cells subjected to genotoxic stress, activation of T cell dependent immune response, and hypertension.
Petr, Kolenko, Daniel, Rozbeský, Ondřej, Vaněk, Vladimír, Kopecký, Kateřina, Hofbauerová, Petr, Novák, Petr, Pompach, Jindřich, Hašek, Tereza, Skálová, Karel, Bezouška, Jan, Dohnálek   +10 more
openaire   +2 more sources